LPL Financial’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.47M | Buy |
15,179
+1,048
| +7% | +$235K | ﹤0.01% | 2962 |
|
|
2025
Q4 | $3.01M | Buy |
14,131
+4,277
| +43% | +$883K | ﹤0.01% | 3012 |
|
|
2025
Q3 | $1.96M | Buy |
9,854
+2,587
| +36% | +$483K | ﹤0.01% | 3331 |
|
|
2025
Q2 | $1.25M | Buy |
7,267
+3,787
| +109% | +$617K | ﹤0.01% | 3544 |
|
|
2025
Q1 | $542K | Sell |
3,480
-719
| -17% | -$103K | ﹤0.01% | 4100 |
|
|
2024
Q4 | $578K | Buy |
4,199
+1,577
| +60% | +$207K | ﹤0.01% | 3966 |
|
|
2024
Q3 | $391K | Sell |
2,622
-252
| -9% | -$34K | ﹤0.01% | 4214 |
|
|
2024
Q2 | $392K | Buy |
2,874
+296
| +11% | +$40.3K | ﹤0.01% | 4066 |
|
|
2024
Q1 | $390K | Sell |
2,578
-276
| -10% | -$39.4K | ﹤0.01% | 3989 |
|
|
2023
Q4 | $359K | Sell |
2,854
-382
| -12% | -$38.1K | ﹤0.01% | 3940 |
|
|
2023
Q3 | $303K | Sell |
3,236
-597
| -16% | -$55.9K | ﹤0.01% | 3914 |
|
|
2023
Q2 | $342K | Buy |
+3,833
| New | +$334K | ﹤0.01% | 3739 |
|
|
2023
Q1 | – | Sell |
-1,736
| Closed | -$212K | – | 4488 |
|
|
2022
Q4 | $212K | Buy |
+1,736
| New | +$202K | ﹤0.01% | 3931 |
|
|
2022
Q3 | – | Sell |
-2,288
| Closed | -$213K | – | 4419 |
|
|
2022
Q2 | $213K | Sell |
2,288
-55
| -2% | -$5.18K | ﹤0.01% | 3893 |
|
|
2022
Q1 | $275K | Sell |
2,343
-393
| -14% | -$45.5K | ﹤0.01% | 3629 |
|
|
2021
Q4 | $368K | Buy |
2,736
+555
| +25% | +$82.6K | ﹤0.01% | 3539 |
|
|
2021
Q3 | $348K | Sell |
2,181
-117
| -5% | -$16K | ﹤0.01% | 3528 |
|
|
2021
Q2 | $302K | Buy |
2,298
+25
| +1% | +$3.33K | ﹤0.01% | 3580 |
|
|
2021
Q1 | $293K | Sell |
2,273
-50
| -2% | -$7.6K | ﹤0.01% | 3478 |
|
|
2020
Q4 | $387K | Sell |
2,323
-206
| -8% | -$34.1K | ﹤0.01% | 2979 |
|
|
2020
Q3 | $390K | Buy |
2,529
+21
| +0.8% | +$3.02K | ﹤0.01% | 2683 |
|
|
2020
Q2 | $371K | Sell |
2,508
-10
| -0.4% | -$1.37K | ﹤0.01% | 2667 |
|
|
2020
Q1 | $284K | Buy |
+2,518
| New | +$327K | ﹤0.01% | 2541 |
|
|
2019
Q3 | – | Sell |
-2,233
| Closed | -$257K | – | 3295 |
|
|
2019
Q2 | $257K | Buy |
2,233
+131
| +6% | +$15.7K | ﹤0.01% | 2827 |
|
|
2019
Q1 | $247K | Buy |
+2,102
| New | +$184K | ﹤0.01% | 2785 |
|
Other funds holding ASND
RCM
ACA
